Unrivaled supply chain and procurement expertise + the transformative power of AI
World-class skills, experience and know-how — amplified by the power of AI
One fact has emerged clearly over the past two years: There are too many uncontrollable variables that can compromise clinical trials.
How can life sciences companies prevent delays and disruptions of their clinical trials? By giving serious thought to decentralizing them. GEP’s new bulletin, Decentralized Clinical Trials: How Procurement Can Help Pharma Companies Prevent and Mitigate Disruptions, defines the necessary criteria to evaluate when outsourcing DCTs. Further, it examines the crucial role procurement has to play in identifying and selecting the right partner.
What’s Inside:
To download and read,
Please Enter your EMAIL ID
JUST A FEW MORE THINGS ABOUT YOU
Theme: Procurement